Critical pathogenic events underlying progression of neurodegeneration in glaucoma

Progress in Retinal and Eye Research

Volumn 31, Issue 6, 2012, Pages 702-719

  Calkins, David J ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Axonal transport; Axonopathy; Dying back; Intraocular pressure; Optic nerve; Optic neuropathy; Retinal ganglion cell; Self repair; Superior colliculus; Wallerian degeneration

Indexed keywords

BRIMONIDINE;

DISEASE COURSE; DISEASE PREDISPOSITION; GLAUCOMA; HUMAN; INTERNEURON; INTRAOCULAR PRESSURE; MITOCHONDRION; MOLECULAR MECHANICS; NERVE CELL; NERVE FIBER; NERVE REGENERATION; NEUROFILAMENT; NONHUMAN; OPTIC NERVE; OXIDATIVE STRESS; PRESYNAPTIC NERVE; PRIORITY JOURNAL; RETINA DEGENERATION; RETINA NERVE CELL; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; DISEASE PROGRESSION; GLAUCOMA; HUMANS; NERVE DEGENERATION; OPTIC DISK; OPTIC NERVE DISEASES; RETINAL GANGLION CELLS;

EID: 84867400662     PISSN: 13509462     EISSN: 18731635     Source Type: Journal    
DOI: 10.1016/j.preteyeres.2012.07.001     Document Type: Review

References (217)

1. Allan V.J. Cytoplasmic dynein. Biochem. Soc. Trans. 2011, 39:1169-1178.
2. Almasieh M., Wilson A.M., Morquette B., Cueva Vargas J.L., Di Polo A. The molecular basis of retinal ganglion cell death in glaucoma. Prog. Retin. Eye Res. 2012, 31:152-181.
3. Ames A. CNS energy metabolism as related to function. Brain Res. Brain Res. Rev. 2000, 34:42-68.
4. Anderson D.R., Hendrickson A. Effect of intraocular pressure on rapid axoplasmic transport in monkey optic nerve. Invest. Ophthalmol. 1974, 13:771-783.
5. Anderson M.G., Smith R.S., Hawes N.L., Zabaleta A., Chang B., Wiggs J.L., John S.W. Mutations in genes encoding melanosomal proteins cause pigmentary glaucoma in DBA/2J mice. Nat. Genet. 2002, 30:81-85.
6. Balaratnasingam C., Morgan W.H., Bass L., Matich G., Cringle S.J., Yu D.Y. Axonal transport and cytoskeletal changes in the laminar regions after elevated intraocular pressure. Invest. Ophthalmol. Vis. Sci. 2007, 48:3632-3644.
7. Baltan S., Inman D.M., Danilov C.A., Morrison R.S., Calkins D.J., Horner P.J. Metabolic vulnerability disposes retinal ganglion cell axons to dysfunction in a model of glaucomatous degeneration. J. Neurosci. 2010, 30:5644-5652.
8. Band L.R., Hall C.L., Richardson G., Jensen O.E., Siggers J.H., Foss A.J. Intracellular flow in optic nerve axons: a mechanism for cell death in glaucoma. Invest. Ophthalmol. Vis. Sci. 2009, 50:3750-3758.
9. Barron M.J., Griffiths P., Turnbull D.M., Bates D., Nichols P. The distributions of mitochondria and sodium channels reflect the specific energy requirements and conduction properties of the human optic nerve head. Br. J. Ophthalmol. 2004, 88:286-290.
10. Bayer A.U., Neuhardt T., May A.C., Martus P., Maag K.P., Brodie S., Lutjen-Drecoll E., Podos S.M., Mittag T. Retinal morphology and ERG response in the DBA/2NNia mouse model of angle-closure glaucoma. Invest. Ophthalmol. Vis. Sci. 2001, 42:1258-1265.
11. Bechtold D.A., Yue X., Evans R.M., Davies M., Gregson N.A., Smith K.J. Axonal protection in experimental autoimmune neuritis by the sodium channel blocking agent flecainide. Brain 2005, 128:18-28.
12. Beirowski B., Babetto E., Coleman M.P., Martin K.R. The WldS gene delays axonal but not somatic degeneration in a rat glaucoma model. Eur. J. Neurosci. 2008, 28:1166-1179.
13. Berkelaar M., Clarke D.B., Wang Y.C., Bray G.M., Aguayo A.J. Axotomy results in delayed death and apoptosis of retinal ganglion cells in adult rats. J. Neurosci. 1994, 14:4368-4374.
14. Bernstein S.L., Guo Y., Slater B.J., Puche A., Kelman S.E. Neuron stress and loss following rodent anterior ischemic optic neuropathy in double-reporter transgenic mice. Invest. Ophthalmol. Vis. Sci. 2007, 48:2304-2310.
15. Bernstein S.L., Mehrabyan Z., Guo Y., Moianie N. Estrogen is not neuroprotective in a rodent model of optic nerve stroke. Mol. Vis. 2007, 13:1920-1925.
16. Bosco A., Inman D.M., Steele M.R., Wu G., Soto I., Marsh-Armstrong N., Hubbard W.C., Calkins D.J., Horner P.J., Vetter M.L. Reduced retina microglial activation and improved optic nerve integrity with minocycline treatment in the DBA/2J mouse model of glaucoma. Invest. Ophthalmol. Vis. Sci. 2008, 49:1437-1446.
17. Bosco A., Steele M.R., Vetter M.L. Early microglia activation in a mouse model of chronic glaucoma. J. Comp. Neurol. 2011, 519:599-620.
18. Braak H., Ghebremedhin E., Rub U., Bratzke H., Del Tredici K. Stages in the development of Parkinson's disease-related pathology. Cell. Tissue Res. 2004, 318:121-134.
19. Bristow E.A., Griffiths P.G., Andrews R.M., Johnson M.A., Turnbull D.M. The distribution of mitochondrial activity in relation to optic nerve structure. Arch. Ophthalmol. 2002, 120:791-796.
20. Buckingham B.P., Inman D.M., Lambert W., Oglesby E., Calkins D.J., Steele M.R., Vetter M.L., Marsh-Armstrong N., Horner P.J. Progressive ganglion cell degeneration precedes neuronal loss in a mouse model of glaucoma. J. Neurosci. 2008, 28:2735-2744.
21. Burgoyne C.F. A biomechanical paradigm for axonal insult within the optic nerve head in aging and glaucoma. Exp. Eye Res. 2011, 93:120-132.
22. Burgoyne C.F., Downs J.C., Bellezza A.J., Suh J.K., Hart R.T. The optic nerve head as a biomechanical structure: a new paradigm for understanding the role of IOP-related stress and strain in the pathophysiology of glaucomatous optic nerve head damage. Prog. Retin. Eye Res. 2005, 24:39-73.
23. Calkins D.J., Horner P.J. The cell and molecular biology of glaucoma: axonopathy and the brain. Invest. Ophthalmol. Vis. Sci. 2012, 53:2482-2484.
24. Calkins D.J., Horner P.J., Roberts R., Gradianu M., Berkowitz B.A. Manganese-enhanced MRI of the DBA/2J mouse model of hereditary glaucoma. Invest. Ophthalmol. Vis. Sci. 2008, 49:5083-5088.
25. Calkins D.J., Sterling P. Absence of spectrally specific lateral inputs to midget ganglion cells in primate retina. Nature 1996, 381:613-615.
26. Callaway E.M. Structure and function of parallel pathways in the primate early visual system. J. Physiol. 2005, 566:13-19.
27. Carelli V., Ross-Cisneros F.N., Sadun A.A. Optic nerve degeneration and mitochondrial dysfunction: genetic and acquired optic neuropathies. Neurochem. Int. 2002, 40:573-584.
28. Carelli V., Rugolo M., Sgarbi G., Ghelli A., Zanna C., Baracca A., Lenaz G., Napoli E., Martinuzzi A., Solaini G. Bioenergetics shapes cellular death pathways in Leber's hereditary optic neuropathy: a model of mitochondrial neurodegeneration. Biochim. Biophys. Acta 2004, 1658:172-179.
29. Chang B., Smith R.S., Hawes N.L., Anderson M.G., Zabaleta A., Savinova O., Roderick T.H., Heckenlively J.R., Davisson M.T., John S.W. Interacting loci cause severe iris atrophy and glaucoma in DBA/2J mice. Nat. Genet. 1999, 21:405-409.
30. Chang D.T., Reynolds I.J. Mitochondrial trafficking and morphology in healthy and injured neurons. Prog. Neurobiol. 2006, 80:241-268.
31. Chang E.E., Goldberg J.L. Glaucoma 2.0: neuroprotection, neuroregeneration, neuroenhancement. Ophthalmology 2012, 119:979-986.
32. Chauhan B.C., Pan J., Archibald M.L., LeVatte T.L., Kelly M.E., Tremblay F. Effect of intraocular pressure on optic disc topography, electroretinography, and axonal loss in a chronic pressure-induced rat model of optic nerve damage. Invest. Ophthalmol. Vis. Sci. 2002, 43:2969-2976.
33. Chen H., Wei X., Cho K.S., Chen G., Sappington R., Calkins D.J., Chen D.F. Optic neuropathy due to microbead-induced elevated intraocular pressure in the mouse. Invest. Ophthalmol. Vis. Sci. 2011, 52:36-44.
34. Chidlow G., Ebneter A., Wood J.P., Casson R.J. The optic nerve head is the site of axonal transport disruption, axonal cytoskeleton damage and putative axonal regeneration failure in a rat model of glaucoma. Acta Neuropathol. 2011, 121:737-751.
35. Choi S.S., Zawadzki R.J., Lim M.C., Brandt J.D., Keltner J.L., Doble N., Werner J.S. Evidence of outer retinal changes in glaucoma patients as revealed by ultrahigh-resolution in vivo retinal imaging. Br. J. Ophthalmol. 2011, 95:131-141.
36. Chrysostomou V., Trounce I.A., Crowston J.G. Mechanisms of retinal ganglion cell injury in aging and glaucoma. Ophthalmic Res. 2010, 44:173-178.
37. Coleman M.P. Axon degeneration mechanisms: commonality amid diversity. Nat. Rev. Neurosci. 2005, 11:889-898.
38. Cone F.E., Gelman S.E., Son J.L., Pease M.E., Quigley H.A. Differential susceptibility to experimental glaucoma among 3 mouse strains using bead and viscoelastic injection. Exp. Eye Res. 2010, 91:415-424.
39. Cordeiro M.F., Guo L., Luong V., Harding G., Wang W., Jones H.E., Moss S.E., Sillito A.M., Fitzke F.W. Real-time imaging of single nerve cell apoptosis in retinal neurodegeneration. Proc. Natl. Acad. Sci. U S A 2004, 101:13352-13356.
40. Cowey A., Alexander I., Stoerig P. Transneuronal retrograde degeneration of retinal ganglion cells and optic tract in hemianopic monkeys and humans. Brain 2011, 134:2149-2157.
41. Crish S.D., Calkins D.J. Neurodegeneration in glaucoma: progression and calcium-dependent intracellular mechanisms. Neuroscience 2011, 176:1-11.
42. Crish S.D., Sappington R.M., Inman D.M., Horner P.J., Calkins D.J. Distal axonopathy with structural persistence in glaucomatous neurodegeneration. Proc. Natl. Acad. Sci. U S A 2010, 107:5196-5201.
43. Cuenca N., Pinilla I., Fernandez-Sanchez L., Salinas-Navarro M., Alarcon-Martinez L., Aviles-Trigueros M., de la Villa P., Miralles de Imperial J., Villegas-Perez M.P., Vidal-Sanz M. Changes in the inner and outer retinal layers after acute increase of the intraocular pressure in adult albino Swiss mice. Exp. Eye Res. 2010, 91:273-285.
44. Curcio C.A., Allen K.A. Topography of ganglion cells in human retina. J. Comp. Neurol. 1990, 300:5-25.
45. Dai C., Khaw P.T., Yin Z.Q., Li D., Raisman G., Li Y. Structural basis of glaucoma: the fortified astrocytes of the optic nerve head are the target of raised intraocular pressure. Glia 2012, 60:13-28.
46. Danias J., Lee K.C., Zamora M.F., Chen B., Shen F., Filippopoulos T., Su Y., Goldblum D., Podos S.M., Mittag T. Quantitative analysis of retinal ganglion cell (RGC) loss in aging DBA/2NNia glaucomatous mice: comparison with RGC loss in aging C57/BL6 mice. Invest. Ophthalmol. Vis. Sci. 2003, 44:5151-5162.
47. De Vos K.J., Grierson A.J., Ackerley S., Miller C.C. Role of axonal transport in neurodegenerative diseases. Annu. Rev. Neurosci. 2008, 31:151-173.
48. Desai D., He S., Yorio T., Krishnamoorthy R.R., Prasanna G. Hypoxia augments TNF-alpha-mediated endothelin-1 release and cell proliferation in human optic nerve head astrocytes. Biochem. Biophys. Res. Commun. 2004, 318:642-648.
49. Doh S.H., Kim J.H., Lee K.M., Park H.Y., Park C.K. Retinal ganglion cell death induced by endoplasmic reticulum stress in a chronic glaucoma model. Brain Res. 2010, 1308:158-166.
50. Drager U.C., Hubel D.H. Topography of visual and somatosensory projections to mouse superior colliculus. J. Neurophysiol. 1976, 39:91-101.
51. Ebneth A., Godemann R., Stamer K., Illenberger S., Trinczek B., Mandelkow E. Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: implications for Alzheimer's disease. J. Cell. Biol. 1998, 143:777-794.
52. Fan N., Huang N., Lam D.S., Leung C.K. Measurement of photoreceptor layer in glaucoma: a spectral-domain optical coherence tomography study. J. Ophthalmol. 2011, 2011:264803.
53. Fernandez D.C., Pasquini L.A., Dorfman D., Aldana Marcos H.J., Rosenstein R.E. Early distal axonopathy of the visual pathway in experimental diabetes. Am. J. Pathol. 2011, 180:303-313.
54. Filippopoulos T., Danias J., Chen B., Podos S.M., Mittag T.W. Topographic and morphologic analyses of retinal ganglion cell loss in old DBA/2NNia mice. Invest. Ophthalmol. Vis. Sci. 2006, 47:1968-1974.
55. Franke H., Krugel U., Illes P. P2 receptors and neuronal injury. Pflugers Arch. 2006, 452:622-644.
56. Fu C.T., Sretavan D. Laser-induced ocular hypertension in albino CD-1 mice. Invest. Ophthalmol. Vis. Sci. 2010, 51:980-990.
57. Garcia-Valenzuela E., Shareef S., Walsh J., Sharma S.C. Programmed cell death of retinal ganglion cells during experimental glaucoma. Exp. Eye Res. 1995, 61:33-44.
58. Godley B.F., Shamsi F.A., Liang F.Q., Jarrett S.G., Davies S., Boulton M. Blue light induces mitochondrial DNA damage and free radical production in epithelial cells. J. Biol. Chem. 2005, 280:21061-21066.
59. Gupta N., Ang L.C., Noel de Tilly L., Bidaisee L., Yucel Y.H. Human glaucoma and neural degeneration in intracranial optic nerve, lateral geniculate nucleus, and visual cortex. Br. J. Ophthalmol. 2006, 90:674-678.
60. Harazny J., Scholz M., Buder T., Lausen B., Kremers J. Electrophysiological deficits in the retina of the DBA/2J mouse. Doc. Ophthalmol. 2009, 119:181-197.
61. Harwerth R.S., Crawford M.L., Frishman L.J., Viswanathan S., Smith E.L., Carter-Dawson L. Visual field defects and neural losses from experimental glaucoma. Prog. Retin. Eye Res. 2002, 21:91-125.
62. Hayreh S.S., Pe'er J., Zimmerman M.B. Morphologic changes in chronic high-pressure experimental glaucoma in rhesus monkeys. J. Glaucoma 1999, 8:56-71.
63. Heiduschka P., Julien S., Schuettauf F., Schnichels S. Loss of retinal function in aged DBA/2J mice - new insights into retinal neurodegeneration. Exp. Eye Res. 2010, 91:779-783.
64. Heijl A., Aspberg J., Bengtsson B. The effect of different criteria on the number of patients blind from open-angle glaucoma. BMC Ophthalmol. 2011, 11:31.
65. Heijl A., Leske M.C., Bengtsson B., Hyman L., Hussein M. Reduction of intraocular pressure and glaucoma progression: results from the early manifest glaucoma trial. Arch. Ophthalmol. 2002, 120:1268-1279.
66. Hendry S.H., Calkins D.J. Neuronal chemistry and functional organization in the primate visual system. Trends Neurosci. 1998, 21:344-349.
67. Hernandez M.R. The optic nerve head in glaucoma: role of astrocytes in tissue remodeling. Prog. Retin. Eye Res. 2000, 19:297-321.
68. Hickman S.J., Brierley C.M., Brex P.A., MacManus D.G., Scolding N.J., Compston D.A., Miller D.H. Continuing optic nerve atrophy following optic neuritis: a serial MRI study. Mult. Scler. 2002, 8:339-342.
69. Ho K.W., Ward N.J., Calkins D.J. TRPV1: a stress response protein in the central nervous system. Am. J. Neurodegener. Dis. 2012, 1:1-14.
70. Holcombe D.J., Lengefeld N., Gole G.A., Barnett N.L. Selective inner retinal dysfunction precedes ganglion cell loss in a mouse glaucoma model. Br. J. Ophthalmol. 2008, 92:683-688.
71. Hollander H., Makarov F., Stefani F.H., Stone J. Evidence of constriction of optic nerve axons at the lamina cribrosa in the normotensive eye in humans and other mammals. Ophthalmic Res. 1995, 27:296-309.
72. Hollenbeck P.J. The pattern and mechanism of mitochondrial transport in axons. Front. Biosci. 1996, 1:d91-102.
73. Hollenbeck P.J., Saxton W.M. The axonal transport of mitochondria. J. Cell. Sci. 2005, 118:5411-5419.
74. Howell G.R., Libby R.T., Jakobs T.C., Smith R.S., Phalan F.C., Barter J.W., Barbay J.M., Marchant J.K., Mahesh N., Porciatti V., Whitmore A.V., Masland R.H., John S.W. Axons of retinal ganglion cells are insulted in the optic nerve early in DBA/2J glaucoma. J. Cell. Biol. 2007, 179:1523-1537.
75. Howell G.R., Libby R.T., Marchant J.K., Wilson L.A., Cosma I.M., Smith R.S., Anderson M.G., John S.W. Absence of glaucoma in DBA/2J mice homozygous for wild-type versions of Gpnmb and Tyrp1. BMC Genet. 2007, 8:45.
76. Howell G.R., Soto I., Libby R.T., John S.W. Intrinsic axonal degeneration pathways are critical for glaucomatous damage. Exp. Neurol 2012, 18 January 2012. http://dx.doi.org/10.1016/j.expneurol.2012.01.014.
77. Howell G.R., Soto I., Zhu X., Ryan M., Macalinao D.G., Sousa G.L., Caddle L.B., Macnicoll K.H., Barbay J.M., Porciatti V., Anderson M.G., Smith R.S., Clark A.F., Libby R.T., John S.W. Radiation treatment inhibits monocyte entry into the optic nerve head and prevents neuronal damage in a mouse model of glaucoma. J. Clin. Invest. 2012, 122:1246-1261.
78. Hsu A., Tsukamoto Y., Smith R.G., Sterling P. Functional architecture of primate cone and rod axons. Vision Res. 1998, 38:2539-2549.
79. Iester M., De Feo F., Douglas G.R. Visual field loss morphology in high- and normal-tension glaucoma. J. Ophthalmol. 2012, 2012:327326.
80. Inman D.M., Horner P.J. Reactive nonproliferative gliosis predominates in a chronic mouse model of glaucoma. Glia 2007, 55:942-953.
81. Inman D.M., Sappington R.M., Horner P.J., Calkins D.J. Quantitative correlation of optic nerve pathology with ocular pressure and corneal thickness in the DBA/2 mouse model of glaucoma. Invest. Ophthalmol. Vis. Sci. 2006, 47:986-996.
82. Jakobs T.C., Libby R.T., Ben Y., John S.W., Masland R.H. Retinal ganglion cell degeneration is topological but not cell type specific in DBA/2J mice. J. Cell. Biol. 2005, 171:313-325.
83. Jiang C., Moore M.J., Zhang X., Klassen H., Langer R., Young M. Intravitreal injections of GDNF-loaded biodegradable microspheres are neuroprotective in a rat model of glaucoma. Mol. Vis. 2007, 13:1783-1792.
84. Jindahra P., Petrie A., Plant G.T. Retrograde trans-synaptic retinal ganglion cell loss identified by optical coherence tomography. Brain 2009, 132:628-634.
85. Johansson J.O. Inhibition and recovery of retrograde axoplasmic transport in rat optic nerve during and after elevated IOP in vivo. Exp. Eye Res. 1988, 46:223-227.
86. John S.W., Smith R.S., Savinova O.V., Hawes N.L., Chang B., Turnbull D., Davisson M., Roderick T.H., Heckenlively J.R. Essential iris atrophy, pigment dispersion, and glaucoma in DBA/2J mice. Invest. Ophthalmol. Vis. Sci. 1998, 39:951-962.
87. Johnson E.C., Morrison J.C. Friend or foe? Resolving the impact of glial responses in glaucoma. J. Glaucoma 2009, 18:341-353.
88. Johnson H., Cowey A. Transneuronal retrograde degeneration of retinal ganglion cells following restricted lesions of striate cortex in the monkey. Exp. Brain Res. 2000, 132:269-275.
89. Kedar S., Ghate D., Corbett J.J. Visual fields in neuro-ophthalmology. Indian J. Ophthalmol. 2011, 59:103-109.
90. Kendell K.R., Quigley H.A., Kerrigan L.A., Pease M.E., Quigley E.N. Primary open-angle glaucoma is not associated with photoreceptor loss. Invest. Ophthalmol. Vis. Sci. 1995, 36:200-205.
91. Kerrigan-Baumrind L.A., Quigley H.A., Pease M.E., Kerrigan D.F., Mitchell R.S. Number of ganglion cells in glaucoma eyes compared with threshold visual field tests in the same persons. Invest. Ophthalmol. Vis. Sci. 2000, 41:741-748.
92. Kerrigan L.A., Zack D.J., Quigley H.A., Smith S.D., Pease M.E. TUNEL-positive ganglion cells in human primary open-angle glaucoma. Arch. Ophthalmol. 1997, 115:1031-1035.
93. Kielczewski J.L., Pease M.E., Quigley H.A. The effect of experimental glaucoma and optic nerve transection on amacrine cells in the rat retina. Invest. Ophthalmol. Vis. Sci. 2005, 46:3188-3196.
94. King W.M., Sarup V., Sauve Y., Moreland C.M., Carpenter D.O., Sharma S.C. Expansion of visual receptive fields in experimental glaucoma. Vis. Neurosci. 2006, 23:137-142.
95. Knox D.L., Eagle R.C., Green W.R. Optic nerve hydropic axonal degeneration and blocked retrograde axoplasmic transport: histopathologic features in human high-pressure secondary glaucoma. Arch. Ophthalmol. 2007, 125:347-353.
96. Lambert W.S., Ruiz L., Crish S.D., Wheeler L.A., Calkins D.J. Brimonidine prevents axonal and somatic degeneration of retinal ganglion cell neurons. Mol. Neurodegener. 2011, 6:4.
97. Lee S., Sato Y., Nixon R.A. Lysosomal proteolysis inhibition selectively disrupts axonal transport of degradative organelles and causes an Alzheimer's-like axonal dystrophy. J. Neurosci. 2011, 31:7817-7830.
98. Lee S., Van Bergen N.J., Kong G.Y., Chrysostomou V., Waugh H.S., O'Neill E.C., Crowston J.G., Trounce I.A. Mitochondrial dysfunction in glaucoma and emerging bioenergetic therapies. Exp. Eye Res. 2010, 93:204-212.
99. Lei Y., Garrahan N., Hermann B., Becker D.L., Hernandez M.R., Boulton M.E., Morgan J.E. Quantification of retinal transneuronal degeneration in human glaucoma: a novel multiphoton-DAPI approach. Invest. Ophthalmol. Vis. Sci. 2008, 49:1940-1945.
100. Lei Y., Garrahan N., Hermann B., Fautsch M.P., Johnson D.H., Hernandez M.R., Boulton M., Morgan J.E. Transretinal degeneration in ageing human retina: a multiphoton microscopy analysis. Br. J. Ophthalmol. 2011, 95:727-730.
101. Leske M.C., Heijl A., Hussein M., Bengtsson B., Hyman L., Komaroff E. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch. Ophthalmol. 2003, 121:48-56.
102. Leske M.C., Heijl A., Hyman L., Bengtsson B., Dong L., Yang Z. Predictors of long-term progression in the early manifest glaucoma trial. Ophthalmology 2007, 114:1965-1972.
103. Levin L.A. Intrinsic survival mechanisms for retinal ganglion cells. Eur. J. Ophthalmol. 1999, 9(Suppl. 1):S12-S16.
104. Levkovitch-Verbin H. Animal models of optic nerve diseases. Eye (Lond.) 2004, 18:1066-1074.
105. Levkovitch-Verbin H., Quigley H.A., Kerrigan-Baumrind L.A., D'Anna S.A., Kerrigan D., Pease M.E. Optic nerve transection in monkeys may result in secondary degeneration of retinal ganglion cells. Invest. Ophthalmol. Vis. Sci. 2001, 42:975-982.
106. Levkovitch-Verbin H., Quigley H.A., Martin K.R., Valenta D., Baumrind L.A., Pease M.E. Translimbal laser photocoagulation to the trabecular meshwork as a model of glaucoma in rats. Invest. Ophthalmol. Vis. Sci. 2002, 43:402-410.
107. Li Y., Jung P., Brown A. Axonal transport of neurofilaments: a single population of intermittently moving polymers. J. Neurosci. 2012, 32:746-758.
108. Libby R.T., Anderson M.G., Pang I.H., Robinson Z.H., Savinova O.V., Cosma I.M., Snow A., Wilson L.A., Smith R.S., Clark A.F., John S.W. Inherited glaucoma in DBA/2J mice: pertinent disease features for studying the neurodegeneration. Vis. Neurosci. 2005, 22:637-648.
109. Libby R.T., Li Y., Savinova O.V., Barter J., Smith R.S., Nickells R.W., John S.W. Susceptibility to neurodegeneration in a glaucoma is modified by Bax gene dosage. PLoS Genet. 2005, 1:17-26.
110. Liu M., Duggan J., Salt T.E., Cordeiro M.F. Dendritic changes in visual pathways in glaucoma and other neurodegenerative conditions. Exp. Eye Res. 2011, 92:244-250.
111. Mabuchi F., Aihara M., Mackey M.R., Lindsey J.D., Weinreb R.N. Optic nerve damage in experimental mouse ocular hypertension. Invest. Ophthalmol. Vis. Sci. 2003, 44:4321-4330.
112. Magharious M.M., D'Onofrio P.M., Koeberle P.D. Optic nerve transection: a model of adult neuron apoptosis in the central nervous system. J. Vis. Exp. 2011.
113. Mallik R., Carter B.C., Lex S.A., King S.J., Gross S.P. Cytoplasmic dynein functions as a gear in response to load. Nature 2004, 427:649-652.
114. McKinnon S.J., Schlamp C.L., Nickells R.W. Mouse models of retinal ganglion cell death and glaucoma. Exp. Eye Res. 2009, 88:816-824.
115. Mihailovic L.T., Cupic D., Dekleva N. Changes in the numbers of neurons and glial cells in the lateral geniculate nucleus of the monkey during retrograde cell degeneration. J. Comp. Neurol. 1971, 142:223-229.
116. Minckler D.S., Bunt A.H., Johanson G.W. Orthograde and retrograde axoplasmic transport during acute ocular hypertension in the monkey. Invest. Ophthalmol. Vis. Sci. 1977, 16:426-441.
117. Minckler D.S., McLean I.W., Tso M.O. Distribution of axonal and glial elements in the rhesus optic nerve head studied by electron microscopy. Am. J. Ophthalmol. 1976, 82:179-187.
118. Mittag T.W., Danias J., Pohorenec G., Yuan H.M., Burakgazi E., Chalmers-Redman R., Podos S.M., Tatton W.G. Retinal damage after 3 to 4 months of elevated intraocular pressure in a rat glaucoma model. Invest. Ophthalmol. Vis. Sci. 2000, 41:3451-3459.
119. Mojumder D.K., Wensel T.G., Frishman L.J. Subcellular compartmentalization of two calcium binding proteins, calretinin and calbindin-28 kDa, in ganglion and amacrine cells of the rat retina. Mol. Vis. 2008, 14:1600-1613.
120. Moon J.I., Kim I.B., Gwon J.S., Park M.H., Kang T.H., Lim E.J., Choi K.R., Chun M.H. Changes in retinal neuronal populations in the DBA/2J mouse. Cell. Tissue Res. 2005, 320:51-59.
121. Moore D.L., Goldberg J.L. Four steps to optic nerve regeneration. J. Neuroophthalmol. 2010, 30:347-360.
122. Morgan J.E. Optic nerve head structure in glaucoma: astrocytes as mediators of axonal damage. Eye (Lond.) 2000, 14(Pt 3B):437-444.
123. Morgan J.E. Circulation and axonal transport in the optic nerve. Eye (Lond.) 2004, 18:1089-1095.
124. Morquette J.B., Di Polo A. Dendritic and synaptic protection: is it enough to save the retinal ganglion cell body and axon?. J. Neuroophthalmol. 2008, 28:144-154.
125. Morrison J.C., Cepurna Ying Guo W.O., Johnson E.C. Pathophysiology of human glaucomatous optic nerve damage: insights from rodent models of glaucoma. Exp. Eye Res. 2011, 93:156-164.
126. Morrison J.C., Johnson E.C., Cepurna W., Jia L. Understanding mechanisms of pressure-induced optic nerve damage. Prog. Retin. Eye Res. 2005, 24:217-240.
127. Morrison J.C., Moore C.G., Deppmeier L.M., Gold B.G., Meshul C.K., Johnson E.C. A rat model of chronic pressure-induced optic nerve damage. Exp. Eye Res. 1997, 64:85-96.
128. Munemasa Y., Kitaoka Y., Kuribayashi J., Ueno S. Modulation of mitochondria in the axon and soma of retinal ganglion cells in a rat glaucoma model. J. Neurochem. 2010, 115:1508-1519.
129. Nagaraju M., Saleh M., Porciatti V. IOP-dependent retinal ganglion cell dysfunction in glaucomatous DBA/2J mice. Invest. Ophthalmol. Vis. Sci. 2007, 48:4573-4579.
130. Nakazawa T., Nakazawa C., Matsubara A., Noda K., Hisatomi T., She H., Michaud N., Hafezi-Moghadam A., Miller J.W., Benowitz L.I. Tumor necrosis factor-alpha mediates oligodendrocyte death and delayed retinal ganglion cell loss in a mouse model of glaucoma. J. Neurosci. 2006, 26:12633-12641.
131. Navarro A., Boveris A. The mitochondrial energy transduction system and the aging process. Am. J. Physiol. Cell Physiol. 2007, 292:C670-C686.
132. Nguyen D., Alavi M.V., Kim K.Y., Kang T., Scott R.T., Noh Y.H., Lindsey J.D., Wissinger B., Ellisman M.H., Weinreb R.N., Perkins G.A., Ju W.K. A new vicious cycle involving glutamate excitotoxicity, oxidative stress and mitochondrial dynamics. Cell. Death Dis. 2011, 2:e240.
133. Nguyen J.V., Soto I., Kim K.Y., Bushong E.A., Oglesby E., Valiente-Soriano F.J., Yang Z., Davis C.H., Bedont J.L., Son J.L., Wei J.O., Buchman V.L., Zack D.J., Vidal-Sanz M., Ellisman M.H., Marsh-Armstrong N. Myelination transition zone astrocytes are constitutively phagocytic and have synuclein dependent reactivity in glaucoma. Proc. Natl. Acad. Sci. U S A 2011, 108:1176-1181.
134. Nicholls D.G., Budd S.L. Mitochondria and neuronal survival. Physiol. Rev. 2000, 80:315-360.
135. Nickells R.W. From ocular hypertension to ganglion cell death: a theoretical sequence of events leading to glaucoma. Can. J. Ophthalmol. 2007, 42:278-287.
136. Nickells R.W., Howell G.R., Soto I., John S.W. Under pressure: cellular and molecular responses during glaucoma, a common neurodegeneration with axonopathy. Annu. Rev. Neurosci. 2012, 35:153-179.
137. Niida T.M.K., Ishikawa S., Iwai E. Transneuronal retrograde degeneration in adult monkey retina following ablation of the striate cortex. Vision, Memory, and the Temporal Lobe 1990, 369-375. Elsevier, New York. E. Iwai, M. Mishkin (Eds.).
138. Niven J.E., Laughlin S.B. Energy limitation as a selective pressure on the evolution of sensory systems. J. Exp. Biol. 2008, 211:1792-1804.
139. Nork T.M., Ver Hoeve J.N., Poulsen G.L., Nickells R.W., Davis M.D., Weber A.J., Vaegan Sarks S.H., Lemley H.L., Millecchia L.L. Swelling and loss of photoreceptors in chronic human and experimental glaucomas. Arch. Ophthalmol. 2000, 118:235-245.
140. Oesch N.W., Kothmann W.W., Diamond J.S. Illuminating synapses and circuitry in the retina. Curr. Opin. Neurobiol. 2011, 21:238-244.
141. Osborne N.N. Mitochondria: their role in ganglion cell death and survival in primary open angle glaucoma. Exp. Eye Res. 2010, 90:750-757.
142. Osborne N.N., Kamalden T.A., Majid A.S., del Olmo-Aguado S., Manso A.G., Ji D. Light effects on mitochondrial photosensitizers in relation to retinal degeneration. Neurochem. Res. 2010, 35:2027-2034.
143. Osborne N.N., Melena J., Chidlow G., Wood J.P. A hypothesis to explain ganglion cell death caused by vascular insults at the optic nerve head: possible implication for the treatment of glaucoma. Br. J. Ophthalmol. 2001, 85:1252-1259.
144. Pang I.H., Clark A.F. Rodent models for glaucoma retinopathy and optic neuropathy. J. Glaucoma 2007, 16:483-505.
145. Pascale A., Drago F., Govoni S. Protecting the retinal neurons from glaucoma: lowering ocular pressure is not enough. Pharmacol. Res. 2012.
146. Pavlidis M., Stupp T., Naskar R., Cengiz C., Thanos S. Retinal ganglion cells resistant to advanced glaucoma: a postmortem study of human retinas with the carbocyanine dye DiI. Invest. Ophthalmol. Vis. Sci. 2003, 44:5196-5205.
147. Pease M.E., McKinnon S.J., Quigley H.A., Kerrigan-Baumrind L.A., Zack D.J. Obstructed axonal transport of BDNF and its receptor TrkB in experimental glaucoma. Invest. Ophthalmol. Vis. Sci. 2000, 41:764-774.
148. Pelzel H.R., Schlamp C.L., Poulsen G.L., Ver Hoeve J.A., Nork T.M., Nickells R.W. Decrease of cone opsin mRNA in experimental ocular hypertension. Mol. Vis. 2006, 12:1272-1282.
149. Perge J.A., Koch K., Miller R., Sterling P., Balasubramanian V. How the optic nerve allocates space, energy capacity, and information. J. Neurosci. 2009, 29:7917-7928.
150. Perge J.A., Niven J.E., Mugnaini E., Balasubramanian V., Sterling P. Why do axons differ in caliber?. J. Neurosci. 2012, 32:626-638.
151. Porciatti V., Nagaraju M. Head-up tilt lowers IOP and improves RGC dysfunction in glaucomatous DBA/2J mice. Exp. Eye Res. 2010, 90:452-460.
152. Quigley H.A. Neuronal death in glaucoma. Prog. Retin. Eye Res. 1999, 18:39-57.
153. Quigley H.A. Selective citation of evidence regarding photoreceptor loss in glaucoma. Arch. Ophthalmol. 2001, 119:1390-1391.
154. Quigley H.A., Addicks E.M. Chronic experimental glaucoma in primates. II. Effect of extended intraocular pressure elevation on optic nerve head and axonal transport. Invest. Ophthalmol. Vis. Sci. 1980, 19:137-152.
155. Quigley H.A., Addicks E.M., Green W.R., Maumenee A.E. Optic nerve damage in human glaucoma. II. The site of injury and susceptibility to damage. Arch. Ophthalmol. 1981, 99:635-649.
156. Quigley H.A., Flower R.W., Addicks E.M., McLeod D.S. The mechanism of optic nerve damage in experimental acute intraocular pressure elevation. Invest. Ophthalmol. Vis. Sci. 1980, 19:505-517.
157. Quigley H.A., McKinnon S.J., Zack D.J., Pease M.E., Kerrigan-Baumrind L.A., Kerrigan D.F., Mitchell R.S. Retrograde axonal transport of BDNF in retinal ganglion cells is blocked by acute IOP elevation in rats. Invest. Ophthalmol. Vis. Sci. 2000, 41:3460-3466.
158. Quigley H.A., Nickells R.W., Kerrigan L.A., Pease M.E., Thibault D.J., Zack D.J. Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis. Invest. Ophthalmol. Vis. Sci. 1995, 36:774-786.
159. Quigley H.A., Sanchez R.M., Dunkelberger G.R., L'Hernault N.L., Baginski T.A. Chronic glaucoma selectively damages large optic nerve fibers. Invest. Ophthalmol. Vis. Sci. 1987, 28:913-920.
160. Raz D., Perlman I., Percicot C.L., Lambrou G.N., Ofri R. Functional damage to inner and outer retinal cells in experimental glaucoma. Invest. Ophthalmol. Vis. Sci. 2003, 44:3675-3684.
161. Reeves T.M., Phillips L.L., Lee N.N., Povlishock J.T. Preferential neuroprotective effect of tacrolimus (FK506) on unmyelinated axons following traumatic brain injury. Brain Res. 2007, 1154:225-236.
162. Reeves T.M., Smith T.L., Williamson J.C., Phillips L.L. Unmyelinated axons show selective rostrocaudal pathology in the corpus callosum after traumatic brain injury. J. Neuropathol. Exp. Neurol. 2012, 71:198-210.
163. Rintoul G.L., Filiano A.J., Brocard J.B., Kress G.J., Reynolds I.J. Glutamate decreases mitochondrial size and movement in primary forebrain neurons. J. Neurosci. 2003, 23:7881-7888.
164. Rintoul G.L., Reynolds I.J. Mitochondrial trafficking and morphology in neuronal injury. Biochim. Biophys. Acta 2010, 1802:143-150.
165. Rosenthal R., Fromm M. Endothelin antagonism as an active principle for glaucoma therapy. Br. J. Pharmacol. 2011, 162:806-816.
166. Saleh M., Nagaraju M., Porciatti V. Longitudinal evaluation of retinal ganglion cell function and IOP in the DBA/2J mouse model of glaucoma. Invest. Ophthalmol. Vis. Sci. 2007, 48:4564-4572.
167. Salinas-Navarro M., Alarcon-Martinez L., Valiente-Soriano F.J., Jimenez-Lopez M., Mayor-Torroglosa S., Aviles-Trigueros M., Villegas-Perez M.P., Vidal-Sanz M. Ocular hypertension impairs optic nerve axonal transport leading to progressive retinal ganglion cell degeneration. Exp. Eye Res. 2010, 90:168-183.
168. Salinas-Navarro M., Alarcon-Martinez L., Valiente-Soriano F.J., Ortin-Martinez A., Jimenez-Lopez M., Aviles-Trigueros M., Villegas-Perez M.P., de la Villa P., Vidal-Sanz M. Functional and morphological effects of laser-induced ocular hypertension in retinas of adult albino Swiss mice. Mol. Vis. 2009, 15:2578-2598.
169. Sappington R.M., Carlson B.J., Crish S.D., Calkins D.J. The microbead occlusion model: a paradigm for induced ocular hypertension in rats and mice. Invest. Ophthalmol. Vis. Sci. 2010, 51:207-216.
170. 2+ with exposure to hydrostatic pressure. Invest. Ophthalmol. Vis. Sci. 2009, 50:717-728.
171. Saylor M., McLoon L.K., Harrison A.R., Lee M.S. Experimental and clinical evidence for brimonidine as an optic nerve and retinal neuroprotective agent: an evidence-based review. Arch. Ophthalmol. 2009, 127:402-406.
172. Schlamp C.L., Li Y., Dietz J.A., Janssen K.T., Nickells R.W. Progressive ganglion cell loss and optic nerve degeneration in DBA/2J mice is variable and asymmetric. BMC Neurosci. 2006, 7:66.
173. Schnitzer M.J., Block S.M. Kinesin hydrolyses one ATP per 8-nm step. Nature 1997, 388:386-390.
174. Scholz M., Buder T., Seeber S., Adamek E., Becker C.M., Lutjen-Drecoll E. Dependency of intraocular pressure elevation and glaucomatous changes in DBA/2J and DBA/2J-Rj mice. Invest. Ophthalmol. Vis. Sci. 2008, 49:613-621.
175. Schuettauf F., Rejdak R., Walski M., Frontczak-Baniewicz M., Voelker M., Blatsios G., Shinoda K., Zagorski Z., Zrenner E., Grieb P. Retinal neurodegeneration in the DBA/2J mouse-a model for ocular hypertension. Acta Neuropathol. 2004, 107:352-358.
176. Sehi M., Grewal D.S., Goodkin M.L., Greenfield D.S. Reversal of retinal ganglion cell dysfunction after surgical reduction of intraocular pressure. Ophthalmology 2010, 117:2329-2336.
177. Sheldon W.G., Warbritton A.R., Bucci T.J., Turturro A. Glaucoma in food-restricted and ad libitum-fed DBA/2NNia mice. Lab. Anim. Sci. 1995, 45:508-518.
178. Sheng Z.H., Cai Q. Mitochondrial transport in neurons: impact on synaptic homeostasis and neurodegeneration. Nat. Rev. Neurosci. 2012, 13:77-93.
179. Shields M.B. Normal-tension glaucoma: is it different from primary open-angle glaucoma?. Curr. Opin. Ophthalmol. 2008, 19:85-88.
180. Shou T., Liu J., Wang W., Zhou Y., Zhao K. Differential dendritic shrinkage of alpha and beta retinal ganglion cells in cats with chronic glaucoma. Invest. Ophthalmol. Vis. Sci. 2003, 44:3005-3010.
181. Son J.L., Soto I., Oglesby E., Lopez-Roca T., Pease M.E., Quigley H.A., Marsh-Armstrong N. Glaucomatous optic nerve injury involves early astrocyte reactivity and late oligodendrocyte loss. Glia 2010, 58:780-789.
182. Soto I., Oglesby E., Buckingham B.P., Son J.L., Roberson E.D., Steele M.R., Inman D.M., Vetter M.L., Horner P.J., Marsh-Armstrong N. Retinal ganglion cells downregulate gene expression and lose their axons within the optic nerve head in a mouse glaucoma model. J. Neurosci. 2008, 28:548-561.
183. Soto I., Pease M.E., Son J.L., Shi X., Quigley H.A., Marsh-Armstrong N. Retinal ganglion cell loss in a rat ocular hypertension model is sectorial and involves early optic nerve axon loss. Invest. Ophthalmol. Vis. Sci. 2011, 52:434-441.
184. Stevens B., Allen N.J., Vazquez L.E., Howell G.R., Christopherson K.S., Nouri N., Micheva K.D., Mehalow A.K., Huberman A.D., Stafford B., Sher A., Litke A.M., Lambris J.D., Smith S.J., John S.W., Barres B.A. The classical complement cascade mediates CNS synapse elimination. Cell 2007, 131:1164-1178.
185. Stokely M.E., Brady S.T., Yorio T. Effects of endothelin-1 on components of anterograde axonal transport in optic nerve. Invest. Ophthalmol. Vis. Sci. 2002, 43:3223-3230.
186. Stys P.K. White matter injury mechanisms. Curr. Mol. Med. 2004, 4:113-130.
187. Takahashi Y., Edamatsu M., Toyoshima Y.Y. Multiple ATP-hydrolyzing sites that potentially function in cytoplasmic dynein. Proc. Natl. Acad. Sci. U S A 2004, 101:12865-12869.
188. Tao J., Rolls M.M. Dendrites have a rapid program of injury-induced degeneration that is molecularly distinct from developmental pruning. J. Neurosci. 2011, 31:5398-5405.
189. Tezel G. TNF-alpha signaling in glaucomatous neurodegeneration. Prog. Brain Res. 2008, 173:409-421.
190. Vaegan Graham S.L., Goldberg I., Buckland L., Hollows F.C. Flash and pattern electroretinogram changes with optic atrophy and glaucoma. Exp. Eye Res. 1995, 60:697-706.
191. Van Buren J.M. The abdominal aura. A study of abdominal sensations occurring in epilepsy and produced by depth stimulation. Electroencephalogr. Clin. Neurophysiol. 1963, 15:1-19.
192. Velten I.M., Korth M., Horn F.K. The a-wave of the dark adapted electroretinogram in glaucomas: are photoreceptors affected?. Br. J. Ophthalmol. 2001, 85:397-402.
193. Venkataraman S.T., Flanagan J.G., Hudson C. Vascular reactivity of optic nerve head and retinal blood vessels in glaucoma-a review. Microcirculation 2010, 17:568-581.
194. Vidal-Sanz M., Lafuente M.P., Mayor S., de Imperial J.M., Villegas-Perez M.P. Retinal ganglion cell death induced by retinal ischemia: neuroprotective effects of two alpha-2 agonists. Surv. Ophthalmol. 2001, 45(Suppl 3):S261-S267. discussion S273-266.
195. Vidal-Sanz M., Salinas-Navarro M., Nadal-Nicolas F.M., Alarcon-Martinez L., Valiente-Soriano F.J., de Imperial J.M., Aviles-Trigueros M., Agudo-Barriuso M., Villegas-Perez M.P. Understanding glaucomatous damage: anatomical and functional data from ocular hypertensive rodent retinas. Prog. Retin. Eye Res. 2012, 31:1-27.
196. Vrabec J.P., Levin L.A. The neurobiology of cell death in glaucoma. Eye (Lond.) 2007, 21(Suppl. 1):S11-S14.
197. Wagner O.I., Lifshitz J., Janmey P.A., Linden M., McIntosh T.K., Leterrier J.F. Mechanisms of mitochondria-neurofilament interactions. J. Neurosci. 2003, 23:9046-9058.
198. Wallace D.C. Mitochondrial diseases in man and mouse. Science 1999, 283:1482-1488.
199. Wang L., Dong J., Cull G., Fortune B., Cioffi G.A. Varicosities of intraretinal ganglion cell axons in human and nonhuman primates. Invest. Ophthalmol. Vis. Sci. 2003, 44:2-9.
200. Wang S.S., Shultz J.R., Burish M.J., Harrison K.H., Hof P.R., Towns L.C., Wagers M.W., Wyatt K.D. Functional trade-offs in white matter axonal scaling. J. Neurosci. 2008, 28:4047-4056.
201. Wang X., Baldridge W.H., Chauhan B.C. Acute endothelin-1 application induces reversible fast axonal transport blockade in adult rat optic nerve. Invest. Ophthalmol. Vis. Sci. 2008, 49:961-967.
202. Wassle H., Boycott B.B. Functional architecture of the mammalian retina. Physiol. Rev. 1991, 71:447-480.
203. Wax M.B., Tezel G., Yang J., Peng G., Patil R.V., Agarwal N., Sappington R.M., Calkins D.J. Induced autoimmunity to heat shock proteins elicits glaucomatous loss of retinal ganglion cell neurons via activated T-cell-derived fas-ligand. J. Neurosci. 2008, 28:12085-12096.
204. Waxman S.G. Prerequisites for conduction in demyelinated fibers. Neurology 1978, 28:27-33.
205. Weber A.J., Chen H., Hubbard W.C., Kaufman P.L. Experimental glaucoma and cell size, density, and number in the primate lateral geniculate nucleus. Invest. Ophthalmol. Vis. Sci. 2000, 41:1370-1379.
206. Weber A.J., Harman C.D. Structure-function relations of parasol cells in the normal and glaucomatous primate retina. Invest. Ophthalmol. Vis. Sci. 2005, 46:3197-3207.
207. Weber A.J., Kaufman P.L., Hubbard W.C. Morphology of single ganglion cells in the glaucomatous primate retina. Invest. Ophthalmol. Vis. Sci. 1998, 39:2304-2320.
208. Whitmore A.V., Libby R.T., John S.W. Glaucoma: thinking in new ways-a role for autonomous axonal self-destruction and other compartmentalised processes?. Prog. Retin. Eye Res. 2005, 24:639-662.
209. Wygnanski T., Desatnik H., Quigley H.A., Glovinsky Y. Comparison of ganglion cell loss and cone loss in experimental glaucoma. Am. J. Ophthalmol. 1995, 120:184-189.
210. Xia J., Lim J.C., Lu W., Beckel J.M., Macarak E.J., Laties A.M., Mitchell C.H. Neurons respond directly to mechanical deformation with pannexin-mediated ATP release and autostimulation of P2X7 receptors. J. Physiol. 2012, 590:2285-2304.
211. Yu Wai Man C.Y., Chinnery P.F., Griffiths P.G. Optic neuropathies-importance of spatial distribution of mitochondria as well as function. Med. Hypotheses 2005, 65:1038-1042.
212. Yucel Y., Gupta N. Glaucoma of the brain: a disease model for the study of transsynaptic neural degeneration. Prog. Brain Res. 2008, 173:465-478.
213. Yucel Y.H., Gupta N., Zhang Q., Mizisin A.P., Kalichman M.W., Weinreb R.N. Memantine protects neurons from shrinkage in the lateral geniculate nucleus in experimental glaucoma. Arch. Ophthalmol. 2006, 124:217-225.
214. Yucel Y.H., Zhang Q., Weinreb R.N., Kaufman P.L., Gupta N. Effects of retinal ganglion cell loss on magno-, parvo-, koniocellular pathways in the lateral geniculate nucleus and visual cortex in glaucoma. Prog. Retin. Eye Res. 2003, 22:465-481.
215. Zhang S., Wang H., Lu Q., Qing G., Wang N., Wang Y., Li S., Yang D., Yan F. Detection of early neuron degeneration and accompanying glial responses in the visual pathway in a rat model of acute intraocular hypertension. Brain Res. 2009, 1303:131-143.
216. Zhong L., Bradley J., Schubert W., Ahmed E., Adamis A.P., Shima D.T., Robinson G.S., Ng Y.S. Erythropoietin promotes survival of retinal ganglion cells in DBA/2J glaucoma mice. Invest. Ophthalmol. Vis. Sci. 2007, 48:1212-1218.
217. Zhu Y., Zhang L., Schmidt J.F., Gidday J.M. Glaucoma-induced degeneration of retinal ganglion cells prevented by hypoxic preconditioning: a model of " glaucoma tolerance" Mol. Med. 2012, Feb 29, [Epub ahead of print]. 10.2119/molmed.2012.00050.